Evaluation of effect of Neurotec medication on the effects of tinnitus symptoms in patients referred to the Baqiatallah hospital in 2016

Introduction: Tinnitus is a relatively common symptom from which one fifth of people between 55 and 65 years of age are suffering. So far, different medical and non-medical treatments have been proposed for Tinnitus which were not able to completely cure it. Thus, finding an alternative medication with lower side effects may be of benefit. Materials and methods: In this double-blind randomized clinical trial patients suffering from tinnitus were randomly allocated to two intervention and control groups. Patients in both groups underwent reassurance and education. Patients in intervention group received Neurotec capsule twice daily for 3 months. Patients in control group received placebo in the same manner as intervention group. Patients were evaluated by visual analogue scale and tinnitus handicap inventory at first and third months of trial. Also pure tone audiometry was done before and after intervention. Results: Eventually 103 (69 male and 34 female) patients with a mean age of 51.33±13.91 years underwent analysis. All Visual Analogue Scale scores as well as Tinnitus Handicap Inventory score were significantly decreased after intervention in Neurotec group (p<0.05). Also there was no sifnificant difference regarding PTA before and after intervention between intervention and control groups.Conclusion: Neurotec significantly reduced all Visual Analogue Scale scores as well as Tinnitus Handicap Inventory score three months after intervention. Also the findings revealed that Neurotec and placebo had no effects on PTA results after intervention.

کلیدواژه ها:

Tinnitus ، Neurotec ، Tansy ، Urtica dioica ، Visual analogue scale ، Tinnitus handicap inventory